IPP Bureau
ASU drug manufacturing licence goes online
By IPP Bureau - October 09, 2021
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
Sanofi says positive results from flu vaccine with mRNA booster study
By IPP Bureau - October 08, 2021
The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older
Cigna sells its life, accident and allied businesses to Chubb for US $ 5.75 billion
By IPP Bureau - October 08, 2021
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
CDSCO approves Syntellix implants
By IPP Bureau - October 08, 2021
This opens up a huge market for the company’s Magnezis implants in India
Lilac Insights launches mental health platform AtEase
By IPP Bureau - October 08, 2021
The platform will provide a safe and nurturing space for women, and non-binary individuals
Thermo Fisher Scientific introduces On the Go mobile app in India
By IPP Bureau - October 07, 2021
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
WHO gives its go-ahead for first-ever malaria vaccine
By IPP Bureau - October 07, 2021
It recommends using the vaccine to prevent the spread of the disease
Twin Health raises US $ 140 million in Series C funding
By IPP Bureau - October 07, 2021
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
Moderna to build mRNA facility in Africa
By IPP Bureau - October 07, 2021
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
Janssen announces novel mechanism that shows promise against dengue
By IPP Bureau - October 07, 2021
Early-stage research suggests the potential to prevent and treat all dengue serotypes and builds on Johnson & Johnson's work to advance science against emerging and entrenched global public health threats
U.S. FDA clears Venclose Maven to treat incompetent perforator veins
By IPP Bureau - October 07, 2021
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
PM Modi dedicates 35 oxygen plants to the nation
By IPP Bureau - October 07, 2021
Now all districts of the country will have commissioned PSA Oxygen plants
PerkinElmer receives FDA Emergency Use Authorization for respiratory SARS-CoV-2 Panel
By IPP Bureau - October 07, 2021
RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus
Cadila Healthcare receives permission to conduct Phase III trials for two-dose ZyCoV-D
By IPP Bureau - October 06, 2021
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
WHO decision on Covaxin approval next week
By IPP Bureau - October 06, 2021
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
